Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: NOTIFY (New Observations Taking Information From Yesterday) [NA]
The NOTIFY trial for Atherosclerotic Cardiovascular Disease sponsored by Stanford University has been withdrawn. No additional trial details…
-
CLINICAL_TRIALS withdrawal · 2025-09-26Clinical Trial Update: Immunomodulatory Effects of PCSK9 Inhibition
A clinical trial examining the immunomodulatory effects of PCSK9 inhibition for cardiovascular disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-18Clinical Trial Update: Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease [NA]
A clinical trial evaluating the effect of switching from cigarette smoking to the Tobacco Heating System (THS) on systemic endothelial funct…
-
CLINICAL_TRIALS withdrawal · 2016-05-11Clinical Trial Update: Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients
A clinical trial evaluating the effectiveness of statins on lipid goal attainment in patients undergoing percutaneous coronary intervention …
-
CLINICAL_TRIALS withdrawal · 2015-12-10Clinical Trial Update: Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease [Phase 2]
Phase 2 proof-of-mechanism study of MLN1202 in stable atherosclerotic cardiovascular disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-06-21Clinical Trial Update: Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis [Phase 2]
A Phase 2 proof-of-concept trial of BMS-823778 for atherosclerotic cardiovascular disease has been withdrawn.